Evidence map›Paper›PMID 32474119›Full record

ArticleGastroenterology2020

Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease.

Charlie W Lees, Miguel Regueiro, Uma Mahadevan, International Organization for the Study of Inflammatory Bowel Disease

Abstract readEditorial
In one paragraph

Article in Gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Models of outpatient care delivery in inflammatory bowel disease: a scoping review.Journal of the Canadian Association of Gastroenterology · 2025
    Article
  5. Review
  6. Exploring the Experiences of Virtual Inflammatory Bowel Disease Care in Saskatchewan.The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advances in Mobile Health for Inflammatory Bowel Disease.Diagnostics (Basel, Switzerland) · 2022
    Review
  12. Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2022
    Article
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Doctor-perceived-barriers to telephone clinics at KwaZulu-Natal hospitals during the COVID-19 pandemic.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2021
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Charlie W LeesInstitute of Genetics & Molecular Medicine, University of Edinburgh, Edinburg, UK.
Miguel RegueiroDepartment of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, Ohio.
Uma MahadevanDivision of Gastroenterology, University of California, San Francisco, San Francisco, California and, Member, International Organization for the study of Inflammatory Bowel Disease.
International Organization for the Study of Inflammatory Bowel Disease

Funding

Medical Research Council MR/S034919/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultBetacoronavirusCoronavirus InfectionsCOVID-19Facilities and Services UtilizationFemaleHumansInflammatory Bowel DiseasesMaleMiddle AgedPandemicsPatient Acceptance of Health CarePneumonia, ViralQuarantineSARS-CoV-2Surveys and Questionnaires

Identifiers

PMID32474119
PMCPMC7256529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.